Morning Symposia

Loading...

2010-12-03 7:00 AM - 11:00 AM

Myelodysplastic Syndromes (MDS): Actively Treating the Disease and Aggressively Supporting the Patient

This program is sponsored by the Cleveland Clinic Center for Continuing Education and supported by the Aplastic Anemia & MDS International Foundation, Inc.

Location: Peabody Orlando Hotel, Orlando Ballroom
Speakers:

Mikkael Sekeres, MD, MS, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
Jaroslaw Maciejewski, MD, PhD, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
Eva Hellström-Lindberg, MD, PhD, Karolinska University, Huddinge University Hospital, Stockholm, Sweden
David P. Steensma, MD, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Aristoteles A.N. Giagounidis, MD, PhD, St. Johannes Hospital, Duisburg, Germany
Gail Roboz, MD, Weill Medical College of Cornell University and New York-Presbyterian, New York, NY
Alice Houk, MS, Aplastic Anemia & MDS International Foundation, Rockville, MD

This satellite symposium will provide an in-depth and up-to-date review of research related to the biology and clinical management of MDS. The overall goal of the program is to bring together leaders in research and clinical practice to explore potential solutions to improving the care of this patient population. Presenters will review the pathobiology and clonal evolution of MDS, disease progression, and treatment approaches for patients.

Contact: Roberta Stavole, Cleveland Clinic Center for Continuing Education
Phone: 216-448-0789
Fax: 216-448-0784
E-mail: stavolr@ccf.org

back to top

Management of Advanced Non-Hodgkin Lymphomas

This program is sponsored by the Medical College of Wisconsin and supported by the National Marrow Donor Program.

Location: Peabody Orlando Hotel, Grand Ballroom R
Speakers:

Ginna Laport, MD, MS, Stanford University, Stanford, CA
Ajay Gopal, MD, Seattle Cancer Care Alliance, Seattle, WA
Philippe Armand, MD, Dana-Farber Cancer Institute, Boston, MA
Julie Vose, MD, Nebraska Medical Center, Omaha, NE
Dennis Confer, MD, National Marrow Donor Program, Minneapolis, MN

Continuously expanding knowledge of the biology of non-Hodgkin lymphomas has led to new treatment strategies for follicular, mantle cell, diffuse large B-cell, and peripheral T-cell lymphomas. In this program, experts will discuss the latest research on standard frontline therapies and salvage therapies, including transplantation and novel agents. Hematologists and oncologists will learn evidence-based approaches to effectively manage these clinically challenging diseases.

Contact: Lyndsey Aspaas, National Marrow Donor Program
Phone: 612-627-8146
Fax: 612-627-5877
E-mail: laspaas@nmdp.org

back to top

Improving Patient Care Through Innovations in Laboratory Medicine: Acute and Chronic Leukemia

This program is sponsored by the Cleveland Clinic Center for Continuing Education and supported by the Wallace H. Coulter Foundation.

 

Location: Peabody Orlando Hotel, Plaza International Ballroom H
Speakers:

Michael Borowitz, MD, PhD, The Johns Hopkins University, Baltimore, MD
Charles Caldwell, MD, University of Missouri – Columbia, Columbia, MO
Andrew Rawstron, BSc, PhD, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
Bharat Thyagarajan, MD, University of Minnesota, Minneapolis, MN

This symposium will cover innovations in laboratory medicine and how they affect the day-to-day management of patients with leukemia. Dr. Borowitz will focus on minimal residual disease testing and its application to treatment assignment for patients with lymphoblastic leukemia. Dr. Caldwell will discuss the use of genetic and epigenetic markers in determining prognosis and management of patients with acute myeloid leukemia. Dr. Rawstron will share his experience with integrating the results of diverse assays in chronic lymphocytic leukemia, IGVH mutational analysis, fluorescence in situ hybridization, and minimal residual disease detection. The symposium will conclude with Dr. Thyagarajan describing how chimerism analysis and other novel methods can be applied to predict and affect outcome following hematopoietic cell transplantation.

Contact: Fiona E. Craig, International Clinical Cytometry Society and International Society for Laboratory Hematology
Phone: 412-647-5191
Fax: 412-647-4008
E-mail: craigfe@upmc.edu

back to top